Image For Activity Cover
Deep Dive into Inclisiran
This activity is part of the Clinical Spotlight Series: The Evolving Lipids Landscape: Current and Emerging Nonstatins.

Accreditation Statement 

In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page. 

Joint Accreditation 
In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 


Credit Statement 

The ACCF designates this online enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.   
While offering the CME credits noted above, this program is not intended to provide extensive training or certification in the field.   

MOC Information 

Successful completion of this certified activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. 
Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

The ACCF designates this educational activity for a maximum of 0.50 continuing nursing education contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.


Physician Assistants 
AAPA Credit Designation Statement 
The American College of Cardiology Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .50 AAPA Category 1 CME credits. 
Approval is valid until September 8, 2022. PAs should only claim credit commensurate with the extent of their participation.


ACCF designates this continuing education activity for 0.50 contact hours of the Accreditation Council for Pharmacy Education. ACPE Universal Activity Number (UAN): JA4008225-0000-21-038-H04-P.   


Target Audience: 

This activity is intended for CV team clinicians who are involved in lipid-lowering treatment planning, including physicians, nurse practitioners, physician assistants, and pharmacists.    

Important Dates: 
Date of Release: September 8, 2021 
Term of Approval/Date of ExpirationSeptember 8, 2022 
Learner Objectives:  
Upon completion of this activity, you should be able to:  

  • Understand the current clinical need for aggressive LDL-C lowering.
  • Review inclisiran as an expanding treatment option for lipid management in high-risk patients.

Educational grant support provided by: Amgen and Novartis Pharmaceuticals Corporation.  



Salim Virani, MD, FACC  

Peer Reviewers: 

Kim Birtcher, PharmD, AACC
Michael D. Miedema, MD, MPH

Availability: On-Demand
Expires on Sep 08, 2022
Cost: FREE
Credit Offered:
0.5 CME Credit
0.5 CNE Credit
0.5 CPE Credit
0.5 AAPA Credit
0.5 ABIM-MOC Point
Android App Download IOS App Download Powered By